Great, another pilot study and another indication where one the...

Great, another pilot study and another indication where one the RCE antibiotics might be beneficial.
Unfortunately, without a proper phase 2 follow up, one that follows a protocol that the FDA will accept, all these pilots and phase 1 studies are useless and a waste of time and resources.
I'd be much happier if RCE for once selects an indication and proceed with and completes a P2 study. The way things move along (I.e. side ways) at the moment does not help bringing a product to market. Moreover, it eats away from the patent protection period.
Not happy with the current lack of direction